Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.18 +0.03 (+1.62%)
As of: Aug 21, 2026 · 1:13 PM EDT

Black Diamond Therapeutics (BDTX) EPS (Diluted) (2020 - 2026)

Black Diamond Therapeutics (BDTX) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.47 Bn 131.61 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 86.36 Bn 78.37 Bn 3.93 Bn 12.23
3 Argenx Se 65.16 Bn 59.98 Bn 1.37 Bn 7.33
4 Moderna 58.99 Bn 53.85 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.08 Bn 36.98 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 31.74 Bn 28.43 Bn 992.69 Mn 1.19
7 BioNTech SE 28.01 Bn 9.61 Bn 668.28 Mn -0.72
8 Insmed 27.50 Bn 26.34 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.28 Bn 26.45 Bn - 0.15
10 Black Diamond Therapeutics 125.35 Mn 14.84 Mn - -0.19

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.20
Mar 31, 2026 -0.20
Dec 31, 2025 -0.31
Sep 30, 2025 -0.27
Jun 30, 2025 -0.23
Mar 31, 2025 0.94
Dec 31, 2024 -0.34
Sep 30, 2024 -0.44
Jun 30, 2024 -0.90
Mar 31, 2024 -0.40
Dec 31, 2023 -0.49
Sep 30, 2023 -1.08
Jun 30, 2023 -0.84
Mar 31, 2023 -0.60
Dec 31, 2022 -0.61
Sep 30, 2022 -1.58
Jun 30, 2022 -0.83
Mar 31, 2022 -0.72
Dec 31, 2021 -0.72
Sep 30, 2021 -1.19